EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Key Causes and Temporal Window of Unplanned Readmissions Following Transsphenoidal Pituitary Surgery: A Systematic Review and Meta-Analysis

Jiajun Chen, Yingyue Zhang, Mengqiang Luo, Ying Huang, Xuehua Che

Journal of Neurological Surgery Part B: Skull Base · 2026-12 · 87 (06) · 685-691

DOI: 10.1055/a-2765-5514 ↗
AbstractBibliografische Angaben

Abstract

Abstract Unplanned readmission (UR) after transsphenoidal pituitary surgery poses a significant healthcare burden, but its exact incidence, causes, and risk factors remain unclear. This meta-analysis aims to estimate the 30-day UR rate, identify its main causes, and explore associated risk factors. A systematic search of PubMed, Embase, Scopus, and Web of Science was conducted from inception to July 2025. Included studies reported 30-day UR rates and risk factors after transsphenoidal pituitary adenoma resection. Pooled incidence rates and odds ratios (ORs) with 95% confidence intervals (CIs) were derived using random-effects models. Heterogeneity was evaluated with I2 statistics, and study quality was assessed using the Newcastle-Ottawa scale. A total of 10 studies with 51,618 patients were included. The pooled 30-day UR rate was 9.68% (95% CI: 7.87–11.91). Hyponatremia (28.67%, 95% CI: 15.30–53.72) and cerebrospinal fluid leak (15.7%, 95% CI: 8.07–30.53) were the most common causes. Both all-cause and hyponatremia-related readmissions clustered early after surgery, with mean times of 9.96 days (95% CI: 6.51–13.42) and 8.05 days (95% CI: 5.86–10.25), respectively, suggesting a shared high-risk window around the first 2 weeks. No risk factor was reported in more than two studies, preventing meta-analysis of predictors. This meta-analysis confirms a high 30-day UR rate (nearly 10%) after transsphenoidal pituitary surgery, primarily due to hyponatremia and CSF leak. The aligned timing of readmissions underscores a critical post-discharge period. These findings emphasize the need for structured follow-up and early intervention—especially extended electrolyte monitoring and complication-specific management—to effectively reduce readmission risk.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →